FI960800A0 - Transdermaaliseen antoon tarkoitettu gestodeeniesteriä sisältävä väline - Google Patents

Transdermaaliseen antoon tarkoitettu gestodeeniesteriä sisältävä väline

Info

Publication number
FI960800A0
FI960800A0 FI960800A FI960800A FI960800A0 FI 960800 A0 FI960800 A0 FI 960800A0 FI 960800 A FI960800 A FI 960800A FI 960800 A FI960800 A FI 960800A FI 960800 A0 FI960800 A0 FI 960800A0
Authority
FI
Finland
Prior art keywords
gestode
transdermal application
containing agents
tests containing
tests
Prior art date
Application number
FI960800A
Other languages
English (en)
Swedish (sv)
Other versions
FI960800A (fi
Inventor
Ralph Lipp
Henry Laurent
Clemens Guenther
Jutta Riedl
Peter Esperling
Ulrich Taeuber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI960800A publication Critical patent/FI960800A/fi
Publication of FI960800A0 publication Critical patent/FI960800A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI960800A 1993-08-26 1996-02-22 Transdermaaliseen antoon tarkoitettu gestodeeniesteriä sisältävä väline FI960800A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4329242A DE4329242A1 (de) 1993-08-26 1993-08-26 Mittel zur transdermalen Applikation enthaltend Gestodenester
PCT/EP1994/002496 WO1995005827A1 (de) 1993-08-26 1994-07-29 Mittel zur transdermalen applikation enthaltend gestodenester

Publications (2)

Publication Number Publication Date
FI960800A FI960800A (fi) 1996-02-22
FI960800A0 true FI960800A0 (fi) 1996-02-22

Family

ID=6496410

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960800A FI960800A0 (fi) 1993-08-26 1996-02-22 Transdermaaliseen antoon tarkoitettu gestodeeniesteriä sisältävä väline

Country Status (10)

Country Link
US (1) US5858394A (fi)
EP (1) EP0715518A1 (fi)
JP (1) JPH09504783A (fi)
AU (1) AU693802B2 (fi)
CA (1) CA2170371A1 (fi)
DE (1) DE4329242A1 (fi)
FI (1) FI960800A0 (fi)
HU (1) HUT73236A (fi)
NO (1) NO960724D0 (fi)
WO (1) WO1995005827A1 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US6540332B2 (en) * 1997-07-15 2003-04-01 Silverbrook Research Pty Ltd Motion transmitting structure for a nozzle arrangement of a printhead chip for an inkjet printhead
US6846496B1 (en) 1999-10-15 2005-01-25 Orion Corporation Treatment of osteoporosis
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US7330822B1 (en) * 2001-05-29 2008-02-12 Oracle International Corporation Methods and systems for managing hierarchically organized and interdependent tasks and issues
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
US6652020B2 (en) * 2002-04-09 2003-11-25 Norco Industries, Inc. Reinforcing bracket for trailer-frame butt joints
ES2270345T3 (es) * 2003-02-21 2007-04-01 Schering Ag Parche transdermico estable frente a los rayos uv.
WO2005058287A2 (en) * 2003-12-12 2005-06-30 Schering Aktiengesellschaft Transdermal delivery system of hormones without penetration enhancers
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US7468470B2 (en) 2004-03-26 2008-12-23 Schering Ag Medicinal patch that leaves less adhesive residue when removed
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
DE2546062A1 (de) * 1975-10-10 1977-04-21 Schering Ag Delta hoch 15 -steroide
HU210549B (en) * 1988-10-27 1995-05-29 Schering Ag Process for producing transdermally applicable pharmaceutical composition containing gestodene
AU657502B2 (en) * 1990-10-29 1995-03-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
JPH0650974A (ja) * 1992-07-29 1994-02-25 Nec Corp 免疫センサシステムおよびこれを用いた免疫測定方法

Also Published As

Publication number Publication date
WO1995005827A1 (de) 1995-03-02
NO960724L (no) 1996-02-23
HUT73236A (en) 1996-07-29
NO960724D0 (no) 1996-02-23
DE4329242A1 (de) 1995-03-02
FI960800A (fi) 1996-02-22
US5858394A (en) 1999-01-12
HU9503654D0 (en) 1996-02-28
AU693802B2 (en) 1998-07-09
EP0715518A1 (de) 1996-06-12
CA2170371A1 (en) 1995-03-02
JPH09504783A (ja) 1997-05-13
AU7533694A (en) 1995-03-21

Similar Documents

Publication Publication Date Title
FI960800A0 (fi) Transdermaaliseen antoon tarkoitettu gestodeeniesteriä sisältävä väline
FI962555A (fi) Kasvittumisenestoaine
DE59309826D1 (de) Statische Mischvorrichtung
DE68928457D1 (de) Energie-härtbare Zusammensetzungen: Zweikomponentenvernetzungsmittel
DE69426197D1 (de) Elektroden für iontophorese
DE69315913D1 (de) Kautschukmischungen
DE69421928D1 (de) Dosierspritze
DE69430205D1 (de) Verpackung für elektroden
DE69404652D1 (de) Analysegerät
DE69517971D1 (de) Nagel zum befestigen von plattenförmigem material
DE69302493D1 (de) Kautschukzusammensetzung
DE69332835D1 (de) Zusammensetzung zum desensibilisieren von zähnen
DE69409775D1 (de) Zusammensetzung zum Beschichten von Kautschuk-Gegenständen
DE69314208D1 (de) Kautschukzusammensetzung
FI955936A0 (fi) Loisten tuhoamisaineita
FI973362A (fi) Transdermaalinen formula
NO307997B1 (no) Ikke-eksplosiv vann-i-olje-kunstgjødselsammensetning
DE69315516D1 (de) Kautschukzusammensetzung
DE69309784D1 (de) Kautschukzusammensetzung
DE69801549D1 (de) Schwalbenschwanzförmige Flüssigkristallverbindung
DE69405896D1 (de) Ladungsträger Analysator
DE69404713D1 (de) Ladungsträger Analysator
DE69604890D1 (de) Flüssige zusammensetzung zur stabilisierung von bypiridinium-herbiziden
DK0565192T3 (da) Indretning til katodisk beskyttelse
NO961769D0 (no) Avlukke for arbeid med giftig substans